PeptideDB

Brevilin A

CAS No.: 16503-32-5

Brevilin A is a sesquiterpene lactone isolated from Centipeda minima, inhibits janus kinase activity and blocks STAT3 si
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Brevilin A is a sesquiterpene lactone isolated from Centipeda minima, inhibits janus kinase activity and blocks STAT3 signaling in cancer cells with anti-tumor activity. Brevilin A is a selective inhibitor of JAK-STAT signal pathway by attenuating the JAKs activity and blocking STAT3 signaling (IC50 = 10.6 μM) in Cancer Cells.Brevilin A induces apoptosis and autophagy via mitochondrial pathway and PI3K/AKT/mTOR inactivation in colon adenocarcinoma cell CT26.antitumour
In vitro In vitro activity against Giardia intestinalis was used for bioassay-guided fractionation of crude extracts from C. minima.?The sesquiterpene lactone, Brevilin A was isolated and found to have antigiardial activity (IC50 = 16.1 μM) and was similarly active in vitro against Entamoeba histolytica (IC50 between 4.5 and 9 μM) and against Plasmodium falciparum (IC50 = 9.42 μM).?
Target activity STAT3 signaling:10.6 µM (IC50)
molecular weight 346.42
Molecular formula C20H26O5
CAS 16503-32-5
Storage store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility DMSO: 100 mg/mL (288.67 mM), Sonication is recommended.
References 1. Antiprotozoal activities of Centipeda minima. Phytother. Res., 1994, 8(8):436-8.